The Healthcare Technology Report with RJ Lumba

Turning Clinical Data Into Evidence: Verantos’ Dan Riskin

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Dan Riskin, CEO and Founder of Verantos, a real-world evidence company focused on generating high-validity evidence for clinical, regulatory, and reimbursement use. Verantos de-identifies, enriches, and integrates data from electronic health records, medical claims, and product and disease registries, then applies artificial intelligence to generate research-grade evidence at scale for life sciences teams.
Dan founded Verantos after building healthcare technology companies at the intersection of medicine and software. He is also a clinical professor of surgery at Stanford and a congressional appointee to the U.S. Health IT Advisory Committee at HHS.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Turning Coverage Into Care: Aeroflow Health’s Casey Hite

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Casey Hite, CEO of Aeroflow Health, a personalized health partner that helps patients access medical equipment and supplies covered by insurance. Aeroflow Health guides patients through product selection, verifies coverage, submits required paperwork, and delivers curated supplies to the patient’s door. The company also partners with health plans and healthcare providers to support member satisfaction and patient care, combining technology with communication, education, and services designed to keep patients informed throughout the process.
Casey co-launched Aeroflow Healthcare in 2002 with his brother Don and has overseen the creation and growth of business lines including Aeroflow Mom & Baby, Motif Medical, Aeroflow Sleep, Aeroflow Urology, and Aeroflow Diabetes.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Bringing GI Therapies to Market: Phathom Pharmaceuticals’ Steve Basta

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Steve Basta, President and CEO of Phathom Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal (GI) diseases. The company has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB) and is building its commercial business around therapies for acid-related GI conditions.
Steve was appointed President and CEO and joined the Board of Directors in April 2025. He brings more than 25 years of leadership experience across biopharmaceutical, medical device, and digital health companies, including CEO roles at SaNOtize, Mahana Therapeutics, Menlo Therapeutics (now VYNE Therapeutics), AlterG, BioForm Medical, and Merz Aesthetics.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Building Enterprise Software Solutions: Jelvix’s Sasha Andrieiev

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Oleksandr (Sasha) Andrieiev, CEO and Co-Founder of Jelvix, a global software engineering company that provides development, integration, and IT consulting services for enterprises, scale-ups, and industry innovators. Jelvix provides custom software development, systems integration, SaaS engineering, and dedicated development teams serving clients across healthcare, financial services, real estate, insurance, and other sectors. With more than 15 years in operation, the company supports organizations throughout North America, Europe, and Asia with long-term technical partnerships.
Andrieiev has led Jelvix since its founding in 2011 and brings experience in entrepreneurship, software development leadership, and advisory work related to digital transformation and technology strategy. Earlier in his career, he built and managed technology-focused businesses in the private sector.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Rewriting Biology at Scale: Constructive Bio’s Ola Wlodek

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Ola Wlodek, CEO of Constructive Bio, a company developing technologies for large-scale genome writing and genetic code reprogramming. Spun out of Professor Jason Chin’s laboratory at the MRC Laboratory of Molecular Biology, Constructive Bio focuses on building programmable biomolecules and enabling cells to produce materials and therapeutics that conventional biology cannot.
Ola brings experience from across the Cambridge biotech ecosystem and previously served as Chief Operating Officer at Reflection Therapeutics. At Constructive Bio, she leads efforts to advance applications of synthetic genomics, from virus-resistant production strains to the biosynthesis of new classes of enzymes, pharmaceuticals, and biomaterials.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Precise Orthopedic Care: restor3d’s Kurt Jacobus

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Kurt Jacobus, Chairman and CEO of restor3d, a company specializing in patient-specific, 3D-printed musculoskeletal implants. Founded in 2017, restor3d combines expertise in additive manufacturing, osseointegrative materials, AI-driven planning tools, and in-house design and manufacturing to support more personalized approaches to orthopaedic care.
Kurt previously led MedShape and Vertera Spine—both acquired by major orthopedic device companies—and has spent much of his career at the intersection of biomedical engineering and medical device innovation. At restor3d, he oversees efforts to bring customized implants to surgeons and hospitals through a fully integrated digital workflow and rapid manufacturing capabilities.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Making Movement Count: Sweatcoin’s Anton Derlyatka

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Anton Derlyatka, Co-Founder and CEO of Sweatcoin, a health and fitness app that encourages people to be more active by turning steps into real-world rewards. Launched in 2015, Sweatcoin has grown into one of the most downloaded health apps globally, reaching more than 200 million users across dozens of countries and partnering with organizations such as the UK’s National Health Service to support population-level health initiatives.
Anton brings experience in building consumer technology products that scale through network effects and user engagement. Under his leadership, the platform has also expanded through partnerships with consumer brands and academic institutions while exploring new applications for behavior-change technology.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.

Advancing Chronic Disease Treatment: Vivani Medical’s Adam Mendelsohn

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Adam Mendelsohn, Co-Founder and CEO of Vivani Medical, a clinical-stage biopharmaceutical company developing miniature, long-term subdermal drug implants to improve treatment outcomes for chronic diseases. Using its proprietary NanoPortal™ technology, Vivani’s lead programs include NPM-115 for chronic weight management, NPM-139 for obesity, and NPM-119 for type 2 diabetes—each designed to maintain consistent medication levels for six months or longer and address the issue of medication non-adherence.
Before leading Vivani, Mendelsohn co-founded Nano Precision Medical, which merged with Second Sight Medical Products in 2022 to form Vivani. He also serves on the board of the Maestro Foundation.
Adam supports The Maestro Foundation. To learn more about this organization click here.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Expanding Autism Care Access: Positive Development’s Mike Suiters

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Mike Suiters, Co-Founder and CEO of Positive Development, a provider of developmental therapy for children with autism. Founded in 2020, the company offers a comprehensive model that integrates speech, occupational, and mental health therapies, serving more than 1,000 families nationwide. 
Positive Development has become the nation’s largest provider of developmental therapy, focused on improving access, affordability, and quality of care. Mike co-founded the company after working at Sandbox Industries’ Blue Venture Fund, where he helped identify innovative healthcare solutions. 
I am your host RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.

Stabilizing Isotope Supply: Nusano’s Chris Lowe

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Chris Lowe, CEO of Nusano, a medical technology company addressing critical shortages in the global radioisotope market. Nusano’s proprietary ion source technology enables the efficient and sustainable production of multiple isotopes simultaneously, supporting cancer therapies, diagnostic imaging, and other essential applications. 
Chris brings more than 20 years of executive experience in healthcare and finance, having raised over $500 million in private and public financing and having completed more than $1 billion in M&A transactions. Prior to Nusano, he served as CFO and COO of Cortexyme, where he guided the company through its IPO and eventual acquisition.
Chris supports American Cancer Society. To learn more about this organization click here.
I am your host RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.